Standout Papers

The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase i... 2001 2026 2009 2017 581
  1. The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo. (2001)
    David W. Rusnak, Karen Lackey et al. PubMed

Immediate Impact

25 by Nobel laureates 48 from Science/Nature 83 standout
Sub-graph 1 of 20

Citing Papers

Challenges and Opportunities in Cancer Drug Resistance
2020 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
1 intermediate paper

Works of Nelson Rhodes being referenced

Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches
2004
The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.
2001 Standout

Author Peers

Author Last Decade Papers Cites
Nelson Rhodes 960 623 84 202 19 1.6k
Andrea Krämer 937 514 23 235 31 1.6k
Maria L. Freilino 808 682 17 338 23 1.5k
Mikhail V. Chernov 1383 933 71 103 15 2.3k
Paul Smith 1063 448 11 74 31 1.8k
María M. Caffarel 610 331 13 105 31 1.5k
Deborah Knee 746 515 7 60 21 1.5k
Waldemar Gonsiorek 548 449 69 86 28 1.9k
Thomas Kirkegaard 1108 190 99 104 32 2.2k
Pierre Olivier Couraud 995 396 12 98 36 2.1k
Nili Feuerstein 1116 258 25 54 42 1.7k

All Works

Loading papers...

Rankless by CCL
2026